In an interview in London, La Repubblica spoke with CEO of AstraZeneca, Pascal Soriot. First on the agenda was why AstraZeneca had failed to provide more details on the supply problem detected in their European plants:

“I think we have been relatively specific with the information. Of course, we are all very disappointed. We would like to produce more. I think we will deliver up to Europe in the month of February a reasonable quantity actually, very similar to what others have delivered on a monthly basis. But of course, it’s less than expected and also because our vaccine is easy to use people expected more so we could scale up. Our team is working 24/7 to fix the very much issues of production of the vaccine itself.